Research Roundup

Debbie Rigby rounds up the latest in research news A Practical Approach to Low-Dose Aspirin for Primary Prevention New clinical trials suggest a reduced benefit of aspirin for preventing first CVD events, but confirm sizable bleeding harms. After a CVD-defining event, use of aspirin, another antiplatelet agent, or both remains mandatory, although aspirin is underused

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Dilemma delayed
Next How do probiotics work?